does any insurance cover glp 1 for weight loss Perspectives from employers on the costs and issues associated with covering GLP-1 agonists are glp-1 drugs covered by

(link to article in the comments) #GLP1s #WeightLossDrugs #EmployeeBenefits To view or add a comment, sign in 27% of employers say GLP-1 weight-loss drugs made up more than 15% of their total annual claims in 2024

106 JacobsonSKDalyJSThorneGMMcIntoshK

Semaglutide, also known by the brand names Wegovy and Ozempic, is a glucagon-like peptide-1 (GLP-1) receptor agonist used to lower blood sugar levels, weight loss, and to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes, obesity, and heart disease

While these injections are generally well tolerated, there are certain gastrointestinal side effects that may occur, such as vomiting, diarrhea, and nausea